View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Novartis AG

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Alnylam Pharmaceuticals Reports Third Quarter 2009 Financial Results

2009 NOV 16 ... Liver Cancer, Liver Carcinoma, Lung Transplant, Marketing and Licensing Agreements, Novartis AG, Oncology, Organ Transplant, Pediatric, Pharmaceutical Business, Pharmaceutical Company, ...

Subject: Alnylam Pharmaceuticals, Inc.

Price: $3.00

ARIAD's AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor

2009 NOV 16 ... Gleevec® and Tasigna® are registered trademarks of Novartis AG, and Sprycel® is a registered trademark of Bristol-Myers Squibb, Inc. ...

Subject: ARIAD Pharmaceuticals

Price: $3.00

Cellerix Raises EUR27 Million in a First Closing

2009 NOV 23 ... Pharmaceuticals, Cell Therapy, Treatment, Biotherapy, Biotechnology, Medical Device, Novartis AG, Pharmaceutical Business, Pharmaceutical Company. This article was prepared ...

Subject: Cellerix Sa

Price: $3.00

Confederation of Indian Industry and U.S.-India Business Council Announce Healthcare Partnership

2009 NOV 16 ... Policy Issues, Public Poli, India, Indian Industry, Marketing and Licensing Agreements, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, U.S.-India Business Council. ...

Subject: U.S.-India Business Council

Price: $3.00

Findings from Novartis in allergies reported

2009 NOV 23 ... 2009;380(4):303-309). For additional information, contact A. Trifilieff, Novartis AG, Novartis Institute BioMed Research, Respiratory Diseases Area, CH-4002 Basel, ...

Subject: Allergies

View Free
Daily News
Article

Hard to Treat Diseases' (HTDS.PK) Update on Various Business Activities

2009 NOV 23 ... Biotechnology, Cancer Vaccines, Drugs, H1N1 Virus, Infectious Disease, Novartis AG, Oncology, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Stem Cell ...

Subject: H1N1 Virus

Price: $3.00

ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders

2009 NOV 23 ... Company Inc., Cancer, Chiron Corporation, GlaxoSmithKline, ImmunoGen, Medarex Inc., Novartis AG, Oncology, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Therapy, ...

Subject: ImmunoGen, Inc.

Price: $3.00

New Downtown LA Social Phenomenon

2009 NOV 23 ... grooming products in 2010. Keywords: BOLT Barbers, Advertising, Marketing, Novartis AG, Pharmaceutical Business, Pharmaceutical Company. This article was prepared ...

Subject: BOLT Barbers

Price: $3.00

New Higher Dose of Focalin XR(R) Improves Control of ADHD Symptoms for Up to 12 Hours

2009 NOV 16 ... in the Group's consolidated balance sheet; and other risks and factors referred to in Novartis AG's current Form 20-F on file with the U.S. Securities and Exchange Commission. Should ...

Subject: Pediatrics

Price: $3.00

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million

2009 NOV 23 ... Clinical Trial Research, Drugs, H1N1 Virus, Immunization, Infectious Disease, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Swine Flu, Swine ...

Subject: H1N1 Virus

Price: $3.00

Novartis to Acquire Majority Stake in Hard to Treat Diseases' HTDS.PK China Subsidiary H1N1 Vaccine Partner for US$125 Million

2009 NOV 23 ... Clinical Trial Research, Drugs, H1N1 Virus, Immunization, Infectious Disease, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Swine Flu, Swine ...

Subject: Hard to Treat Diseases HTDS

Price: $3.00

Pharmaceutical Employer Market Strategies: Influencing the Influencers

2009 NOV 23 ... Biotechnology Business, Biotechnology Company, Drugs, Genentech Inc., Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Therapies, Therapy, ...

Subject: Pharmaceuticals

Price: $3.00

Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More

2009 NOV 16 ... F. Leading Players in the Market F.1 AstraZeneca Plc F.2 Pfizer Inc F.3 Novartis AG G. Appendix G.1 Offshoring in the Pharmaceutical Sector G.2.1 Offshoring of ...

Subject: Research and Markets Ltd.

Price: $3.00

Pulmatrix Closes $30.2 Million in Series B Financing

2009 NOV 16 ... Research, Clinical Trials, Congenital Lobar Emphysema, Drug Development, Flu, Influenza, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Pre-Trials Research, Pulmonology, ...

Subject: Pulmatrix

Price: $3.00

Research on hematopoietic reported by M. Xaymardan et al

2009 NOV 16 ... Drugs, Enzymes, Gleevec, Hematology, Hematopoietic, Imatinib, Imatinib Mesylate, Kinase, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Protein Kinase ...

Subject: Hematopoietic

Price: $3.00

Researchers at University of Manchester publish new data on pharmacokinetics in children

2009 NOV 9 ... United Kingdom, Manchester, Antiviral, Clinical Pharmacology, Drugs, Famciclovir, Novartis AG, Pediatrics, Penciclovir, Pharmaceutical Business, Pharmaceutical Company, ...

Subject: Pharmacokinetics

Price: $3.00

Researchers from Novartis describe findings in pharmacokinetics

2009 NOV 16 ... Germany. Keywords: Switzerland, Basel, Clinical Pharmacology, Drugs, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pharmacokinetics, ...

Subject: Pharmacokinetics

View Free
Daily News
Article

Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health

2009 NOV 16 ... Detection, Diagnostics, GlaxoSmithKline, Lung Cancer, Lung Neoplasms, Medical Device, Novartis AG, Oncology, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Therapy, ...

Subject: Lung Cancer

Price: $3.00

Study results from Austin Hospital provide new insights into obstructive sleep apnea

2009 NOV 23 ... Bariatrics, Cardiology, Cardiovascular, Clinical Trial Research, Craniofacial, Novartis AG, Obesity, Obstructive Sleep Apnea, Otolaryngology, Pharmaceutical Business, ...

Subject: Obstructive Sleep Apnea

Price: $3.00

The Global Sourcing Forum + Expo Puts the Spotlight on CIOs, CFOs and COOs with Two Special Roundtables

2009 NOV 16 ... Electronics, Finance, Financial, Insurance, Investing, Investment, Technology, Novartis AG, Pharmaceutical Business, Pharmaceutical Company. This article was prepared ...

Subject: OutsourceWorld

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx